Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

Novartis is buying gene therapy and neuroscience biotech Kate Therapeutics in a deal worth $1.1 billion in upfront and milestone payments, the Swiss pharma confirmed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Transforming Shots Into Pills; ‘Tip of the Iceberg’ for TILs? Food Additives Warning

A California startup has the lofty goal of transforming blockbuster injectable and infusional drugs into pills. (Endpoints News) Johnson & Johnson announced FDA approval of

February 24, 2024

Covid-19 Isn’t Over: Hospitalizations Ups, Vaccines Down and Cannabis Reducing Symptoms?

Between December 30th, 2023, and January 8, 2024, there were 34,7981 people hospitalized due to Covid-19. This is a big jump of 20.4%2 from the

February 23, 2024

‘The response defies belief’: Year of inaction leaves children at risk from bad cancer drugs

A year after an investigation revealed widespread use of a substandard cancer drug, the World Health Organization and national drug regulators around the world have

January 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.